Healthcare

EBR Systems Inc (ASX:EBR) shares traded at $0.130 during the trading session on 30 October 2026, rising 8.33%. The S&P/ASX 200 (ASX:XJO) stood at 8,973.00, up 0.91% or 81.20 points at 11:15 am. EBR is a Santa Clara, California developer of a wireless cardiac …

Three ASX-listed healthcare companies with products in regulatory review or clinical development traded higher during theTrading sessionon 30 October 2026. EBR Systems Inc (ASX:EBR) traded at $0.130, up 8.33%, Recce Pharmaceuticals Ltd (ASX:RCE) at $0.360, up 9.09%, and Ceretas Ltd (ASX:CTS) at $0.975, up …

Recce Pharmaceuticals Ltd (ASX:RCE) shares traded at $0.360 during the trading session on 30 October 2026, rising 9.09%. The S&P/ASX 200 (ASX:XJO) stood at 8,973.00, up 0.91% or 81.20 points at 11:15 am. Recce is a clinical-stage biotechnology company developing synthetic anti-infectives, with its …

Ansell Limited (ASX:ANN) was trading at AUD 46.26, down 0.52% at the 27 October 2026 close. The company’s reported results and operating disclosures cover the financial performance,Businessactivities and other corporate measures described below.

The audited Appendix 4E reportedRevenueof $1,716,656, up 284.7%, which is interest received on bank accounts, and a net loss after tax of $23,400,949, up 92.6% from $12,147,828. Cash was $37,317,962 at 30 June 2026, against $33,158,642 a year earlier.

In its 27 October 2026 report, Botanix said prescriptions shipped grew 5.3% to 35,130 from 33,358 in Q4 FY26, following a resizing of the sales force from 50 to 39 completed on 31 July 2026. Average gross-to-netYieldwas 21% against 22%, which the company attributed …

In its 8 September 2026 announcement, BTC Health said Arna Pharma was placed into voluntary administration on 7 September 2026 after its board appointed administrators. Arna makes Bronchitol and Aridol, both TGA-registered, with Bronchitol listed on the Pharmaceutical Benefits Scheme, and both are manufactured …